ArticleCancer biology & medicine2023

Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer.

Ming Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.